O ORUKA THERAPEUTICS INC
| Market Cap | $2.64B |
| P/E Ratio | — |
| Forward P/E | -21.17 |
| Dividend Yield | — |
| Beta | — |
| 52W Range | $6.78 - $53.31 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 0.21% | $80.83M | 2,666,690 | — |
Insider Trading
| Insider Name of the company insider who made the trade 24 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Quinlan Paul TGeneral Counsel | Sale | 733 | $41.30 | $30.27K | 16 Mar 2026 | 16 Mar 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 641 | $41.30 | $26.47K | 16 Mar 2026 | 16 Mar 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 1,177 | $41.94 | $49.36K | 16 Mar 2026 | 16 Mar 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 2,902 | $41.20 | $119.57K | 16 Mar 2026 | 16 Mar 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 2,921 | $40.11 | $117.16K | 16 Mar 2026 | 16 Mar 2026 |
| Agarwal ArjunSenior Vice President, Finance | Sale | 395 | $41.30 | $16.31K | 16 Mar 2026 | 16 Mar 2026 |
| Klein Lawrence OttoChief Executive Officer | Sale | 1,729 | $41.30 | $71.41K | 16 Mar 2026 | 16 Mar 2026 |
| Sandler Laura LeeChief Operating Officer | Sale | 600 | $41.30 | $24.78K | 16 Mar 2026 | 16 Mar 2026 |
| Sandler Laura LeeChief Operating Officer | Sale | 2,675 | $33.81 | $90.44K | 02 Mar 2026 | 02 Mar 2026 |
| Sandler Laura LeeChief Operating Officer | Sale | 2,325 | $33.28 | $77.39K | 02 Mar 2026 | 02 Mar 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 936 | $32.78 | $30.69K | 17 Feb 2026 | 17 Feb 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 6,064 | $32.30 | $195.87K | 17 Feb 2026 | 17 Feb 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 2,619 | $32.24 | $84.43K | 15 Jan 2026 | 16 Jan 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 4,381 | $31.56 | $138.28K | 15 Jan 2026 | 16 Jan 2026 |
| Sandler Laura LeeChief Operating Officer | Sale | 1,108 | $29.75 | $32.97K | 02 Jan 2026 | 02 Jan 2026 |
| Sandler Laura LeeChief Operating Officer | Sale | 3,144 | $29.08 | $91.43K | 02 Jan 2026 | 02 Jan 2026 |
| Sandler Laura LeeChief Operating Officer | Sale | 8,748 | $28.17 | $246.40K | 02 Jan 2026 | 02 Jan 2026 |
| Laura Lee SandlerChief Operating Officer | Sale | 1,108 | $29.75 | $32.97K | 02 Jan 2026 | 02 Jan 2026 |
| Laura Lee SandlerChief Operating Officer | Sale | 3,144 | $29.08 | $91.43K | 02 Jan 2026 | 02 Jan 2026 |
| Laura Lee SandlerChief Operating Officer | Sale | 8,748 | $28.17 | $246.40K | 02 Jan 2026 | 02 Jan 2026 |
| Goncalves JoanaChief Medical Officer | Sale | 3,080 | $31.58 | $97.26K | 19 Dec 2025 | 19 Dec 2025 |
| Goncalves JoanaChief Medical Officer | Sale | 1,492 | $30.70 | $45.81K | 19 Dec 2025 | 19 Dec 2025 |
| Goncalves JoanaChief Medical Officer | Sale | 1,787 | $29.62 | $52.93K | 19 Dec 2025 | 19 Dec 2025 |
| Goncalves JoanaChief Medical Officer | Sale | 641 | $28.53 | $18.29K | 19 Dec 2025 | 19 Dec 2025 |
Frequently Asked Questions
What is ORKA stock price today?
ORUKA THERAPEUTICS INC (ORKA) is currently trading at $53.31. The stock has a 52-week range of $6.78 to $53.31 and a market capitalization of $2.64B.
Is ORKA a good stock to buy in 2026?
ORUKA THERAPEUTICS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +497.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ORKA stock?
There have been 24 insider transactions for ORKA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ORKA stock performed over the past year?
ORUKA THERAPEUTICS INC (ORKA) has returned +497.6% over the past 12 months. The stock traded between $6.78 and $53.31 during this period, and is currently at $53.31.
Which hedge funds own ORKA (ORUKA THERAPEUTICS INC)?
1 tracked hedge funds currently hold ORKA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ORKA's market cap and valuation?
ORUKA THERAPEUTICS INC (ORKA) has a market capitalization of $2.64B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is ORKA's revenue and profitability?
ORUKA THERAPEUTICS INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of N/A.
What sector is ORKA in and who are its biggest institutional holders?
ORUKA THERAPEUTICS INC (ORKA) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.